Inhibitions of AChE decrease the hydrolysis of ACh in the brain and increase cholinergic neurotransmissions which might be helpful in treating mild to moderate levels of Alzheimer’s disease. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.